236 related articles for article (PubMed ID: 26572091)
1. N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor.
Hansen LS; Sparre-Ulrich AH; Christensen M; Knop FK; Hartmann B; Holst JJ; Rosenkilde MM
Br J Pharmacol; 2016 Mar; 173(5):826-38. PubMed ID: 26572091
[TBL] [Abstract][Full Text] [Related]
2. GIP(3-30)NH
Sparre-Ulrich AH; Gabe MN; Gasbjerg LS; Christiansen CB; Svendsen B; Hartmann B; Holst JJ; Rosenkilde MM
Biochem Pharmacol; 2017 May; 131():78-88. PubMed ID: 28237651
[TBL] [Abstract][Full Text] [Related]
3. Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors.
Sparre-Ulrich AH; Hansen LS; Svendsen B; Christensen M; Knop FK; Hartmann B; Holst JJ; Rosenkilde MM
Br J Pharmacol; 2016 Jan; 173(1):27-38. PubMed ID: 26359804
[TBL] [Abstract][Full Text] [Related]
4. Human GIP(3-30)NH
Gabe MBN; Sparre-Ulrich AH; Pedersen MF; Gasbjerg LS; Inoue A; Bräuner-Osborne H; Hartmann B; Rosenkilde MM
Biochem Pharmacol; 2018 Apr; 150():97-107. PubMed ID: 29378179
[TBL] [Abstract][Full Text] [Related]
5. GIP-(3-42) does not antagonize insulinotropic effects of GIP at physiological concentrations.
Deacon CF; Plamboeck A; Rosenkilde MM; de Heer J; Holst JJ
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E468-75. PubMed ID: 16608883
[TBL] [Abstract][Full Text] [Related]
6. GIP(3-30)NH
Gasbjerg LS; Christensen MB; Hartmann B; Lanng AR; Sparre-Ulrich AH; Gabe MBN; Dela F; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
Diabetologia; 2018 Feb; 61(2):413-423. PubMed ID: 28948296
[TBL] [Abstract][Full Text] [Related]
7. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.
Tseng CC; Kieffer TJ; Jarboe LA; Usdin TB; Wolfe MM
J Clin Invest; 1996 Dec; 98(11):2440-5. PubMed ID: 8958204
[TBL] [Abstract][Full Text] [Related]
8. GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
Gelling RW; Coy DH; Pederson RA; Wheeler MB; Hinke S; Kwan T; McIntosh CH
Regul Pept; 1997 Apr; 69(3):151-4. PubMed ID: 9226399
[TBL] [Abstract][Full Text] [Related]
9. Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.
Gabe MBN; van der Velden WJC; Smit FX; Gasbjerg LS; Rosenkilde MM
Peptides; 2020 Mar; 125():170224. PubMed ID: 31809770
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.
Wheeler MB; Gelling RW; McIntosh CH; Georgiou J; Brown JC; Pederson RA
Endocrinology; 1995 Oct; 136(10):4629-39. PubMed ID: 7664683
[TBL] [Abstract][Full Text] [Related]
11. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
12. GIP-derived GIP receptor antagonists - a review of their role in GIP receptor pharmacology.
Rosenkilde MM; Lindquist P; Kizilkaya HS; Gasbjerg LS
Peptides; 2024 Jul; 177():171212. PubMed ID: 38608836
[TBL] [Abstract][Full Text] [Related]
13. GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men.
Skov-Jeppesen K; Svane MS; Martinussen C; Gabe MBN; Gasbjerg LS; Veedfald S; Bojsen-Møller KN; Madsbad S; Holst JJ; Rosenkilde MM; Hartmann B
Bone; 2019 Aug; 125():178-185. PubMed ID: 31100534
[TBL] [Abstract][Full Text] [Related]
14. GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals.
Gasbjerg LS; Helsted MM; Hartmann B; Sparre-Ulrich AH; Veedfald S; Stensen S; Lanng AR; Bergmann NC; Christensen MB; Vilsbøll T; Holst JJ; Rosenkilde MM; Knop FK
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32077470
[TBL] [Abstract][Full Text] [Related]
15. Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP).
Hinke SA; Manhart S; Pamir N; Demuth H; W Gelling R; Pederson RA; McIntosh CH
Biochim Biophys Acta; 2001 May; 1547(1):143-55. PubMed ID: 11343800
[TBL] [Abstract][Full Text] [Related]
16. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
Yuliantie E; Darbalaei S; Dai A; Zhao P; Yang D; Sexton PM; Wang MW; Wootten D
Biochem Pharmacol; 2020 Jul; 177():114001. PubMed ID: 32360365
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP production and insulin releasing activity of synthetic fragment peptides of glucose-dependent insulinotropic polypeptide.
Gault VA; Harriott P; Flatt PR; O'Harte FP
Biosci Rep; 2002; 22(5-6):523-8. PubMed ID: 12635849
[TBL] [Abstract][Full Text] [Related]
19. Structural and pharmacological characterization of novel potent and selective monoclonal antibody antagonists of glucose-dependent insulinotropic polypeptide receptor.
Ravn P; Madhurantakam C; Kunze S; Matthews E; Priest C; O'Brien S; Collinson A; Papworth M; Fritsch-Fredin M; Jermutus L; Benthem L; Gruetter M; Jackson RH
J Biol Chem; 2013 Jul; 288(27):19760-72. PubMed ID: 23689510
[TBL] [Abstract][Full Text] [Related]
20. GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment.
Gabe MBN; Skov-Jeppesen K; Gasbjerg LS; Schiellerup SP; Martinussen C; Gadgaard S; Boer GA; Oeke J; Torz LJ; Veedfald S; Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ; Hartmann B; Rosenkilde MM
Pharmacol Res; 2022 Feb; 176():106058. PubMed ID: 34995796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
